Dose-dependent suppression of human glioblastoma xenograft growth by accelerator-based boron neutron capture therapy with simultaneous use of two boron-containing compounds › Research Explorer

DOI

https://doi.org/10.3390/biology10111124
Final published version

Vladimir Kanygin
Ivan Razumov
Alexander Zaboronok
Evgenii Zavjalov
Aleksandr Kichigin
Olga Solovieva
Alphiya Tsygankova
Tatiana Guselnikova
Dmitrii Kasatov
Tatiana Sycheva
Bryan J. Mathis
Sergey Taskaev

Original language	English
Article number	1124
Journal	Biology
Volume	10
Issue number	11
DOIs	https://doi.org/10.3390/biology10111124
Publication status	Published - Nov 2021

OECD FOS+WOS

1.06.CQ BIOCHEMISTRY & MOLECULAR BIOLOGY

Research areas

Accelerator-based neutron source, Animal tumor model, Boron compounds, Boron neutron capture therapy, Boronophenylalanine, Glioblastoma, Sodium borocaptate

ID: 34642422